Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children [Phase 4]
A Phase 4 pilot clinical trial is evaluating an asthma management program for inner-city Early Head Start children; current status is unknow…
-
FDA approval · 2009-09-15FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Advair HFA (fluticasone propionate and salmeterol xinafoate) from GlaxoSmithKline. The action up…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: TELICAST : Telithromycin in Acute Exacerbations of Asthma [Phase 3]
Phase 3 trial of telithromycin for acute exacerbations of asthma has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Efficacy and Safety of Two Dry Power Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma [Phase 3]
A Phase 3 study evaluated the efficacy and safety of two dry powder inhalers delivering mometasone furoate for asthma; the trial has complet…
-
FDA approval · 2009-09-08FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for albuterol sulfate by Sandoz Inc, updating an existing approved product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects [Phase 4]
A Phase 4 trial of Advair (fluticasone propionate/salmeterol) in asthmatic subjects has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: Interleukin (IL)-13 as a Marker in Pediatrics Asthma
This completed clinical trial evaluated Interleukin-13 as a biomarker in pediatric asthma.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: Oral Bacteria and Allergic Disease in Children
A NIEHS-sponsored trial investigating oral bacteria and allergic disease in children has completed. The study covered asthma, allergic rhini…
-
FDA approval · 2009-08-21FDA Approved: ZAFIRLUKAST — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Zafirlukast submitted by Strides Pharma Science Limited.
-
FDA label_change · 2009-08-21FDA Approved: ZYFLO — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for ZYFLO (zileuton) from Chiesi USA, Inc., resulting in a labeling change.
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Feedback Reports and e-Learning in Primary Care Spirometry [Phase 4]
A Phase 4 clinical trial update about feedback reports and e-learning in primary care spirometry; the study has completed.
-
FDA approval · 2009-08-19FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a Supplemental Application for Singulair (montelukast sodium) submitted by Organon LLC. This action typically results in labeli…
-
FDA approval · 2009-08-19FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Singulair(R) In Asthma And Allergic Rhinitis (0476-383) [Phase 4]
Phase 4 clinical trial update on Singulair (montelukast) in asthma, with indications for allergic rhinitis noted; results posted in 2009 and…
-
CLINICAL_TRIALS research · 2009-08-18Clinical Trial Update: Comparison of On-line and Off-line Measurements of Exhaled Nitric Oxide (NO)
This clinical trial update compares online versus offline measurements of exhaled nitric oxide (NO) in asthma and primary ciliary dyskinesia…
-
CLINICAL_TRIALS trial_result · 2009-08-17Clinical Trial Update: Study Of RV-39 In Patients Who Also Have Asthma [Phase 4]
A Phase 4 trial of RV-39 in patients with asthma was terminated, with results posted in August 2009 by sponsor GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: Effect of Inhaled Steroids on Glucose Regulation in Asthma Patients
A completed study assessing the impact of inhaled corticosteroids on glucose regulation in patients with asthma.
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: The Effect of Long Term Inhaled Corticosteroids on the Risk of Cardiovascular Morbidities
A completed clinical trial evaluating whether long-term inhaled corticosteroids influence the risk of cardiovascular morbidities in asthma p…
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Vitamin D for the Treatment of Severe Asthma [Phase 4]
A Phase 4 clinical trial evaluating vitamin D for the treatment of severe asthma; the study status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2009-08-12Clinical Trial Update: The Effect of Asthma on Systemic Inflammation, Oxidative Stress and Cardiovascular Morbidity
A completed clinical trial assessing whether asthma affects systemic inflammation, oxidative stress, and cardiovascular morbidity.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301) [Phase 3]
A Phase 3 trial evaluating an intravenous drug in pediatric patients with acute asthma has completed, with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Study Evaluating Etanercept in Moderate to Severe Asthma [Phase 2]
A Phase 2 study evaluating etanercept for moderate to severe asthma has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Study of Salmeterol (SN408D) for Adult Asthma [Phase 4]
Phase 4 clinical trial completion update for Salmeterol (SN408D) in adult asthma, sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study- [Phase 3]
Phase 3 pediatric trial assessing the Salmeterol/Fluticasone Propionate HFA MDI combination in asthma has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464) [Phase 3]
Phase 3 trial evaluating whether 36 months of levocetirizine can prevent asthma in young children with eczema; the study was terminated and …